Atlas Trials

COVID-19 Vaccine Response in Sickle Cell Disease

Clinical trial NCT05139992 · COMPLETED

Trial details

NCT number
NCT05139992
Sponsor
ASH Research Collaborative
Status
COMPLETED
Study type
OBSERVATIONAL
Sickle Cell DiseaseCOVID-19
Start date
2021-12-01
Primary completion
2023-12-31
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.